Literature DB >> 14570367

Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival.

Ming-Sing Si1, Farin Amersi, S Raymond Golish, Jorge A Ortiz, Joseph Zaky, Debbie Finklestein, Ronald W Busuttil, David K Imagawa.   

Abstract

The purpose of this study was to determine the prevalence and risk factors of metastases in hepatocellular carcinoma (HCC) patients and analyze the effects of different locations of metastases on survival. Retrospective analysis was performed on 347 HCC patients who received a metastatic workup including bone scan and computed tomography scans of chest, abdomen, and pelvis. Clinical and tumor characteristics were evaluated as risk factors for metastasis by univariate and multivariate methods. Survival was analyzed by Kaplan-Meier and Cox regression methods. One hundred forty-five patients had metastases: 72 had thoracic, 57 had abdominal, and 34 had bone metastases. Significant differences were noted with weight loss, hepatitis C, tumor grade, tumor multifocality, size, and alkaline phosphatase levels between the metastases group and the nonmetastases group by univariate analysis. Poor differentiation, multilobar spread, and size (> or = 5 cm) were strongest predictors of metastatic disease by logistic regression. Patients with thoracic metastases had significantly poorer survival. HCC metastasis is prevalent on initial presentation. Evaluation for liver transplantation or curative resection requires a full metastatic workup. Poor differentiation, larger tumors, and those with multilobar spread have increased risk for metastasis. Patients with thoracic spread have poor prognosis as compared to other locations of metastasis.

Entities:  

Mesh:

Year:  2003        PMID: 14570367

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  35 in total

1.  Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.

Authors:  Li Zhou; Jing-An Rui; Da-Xiong Ye; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

2.  A case of recurrent metastatic hepatocellular cancer controlled with immunotherapy and antiviral therapy following resection.

Authors:  Saadettin Kilickap; Ayse Kars; Erhan Hamaloglu; Halis Simsek
Journal:  Med Oncol       Date:  2009-08-18       Impact factor: 3.064

3.  Diagnostic value for extrahepatic metastases of hepatocellular carcinoma in positron emission tomography/computed tomography scan.

Authors:  Ji Eun Lee; Jae Young Jang; Soung Won Jeong; Sae Hwan Lee; Sang Gyune Kim; Sang-Woo Cha; Young Seok Kim; Young Deok Cho; Hong Soo Kim; Boo Sung Kim; So Young Jin; Deuk Lin Choi
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

4.  Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.

Authors:  Seanthan Senthilnathan; Khairuddin Memon; Robert J Lewandowski; Laura Kulik; Mary F Mulcahy; Ahsun Riaz; Frank H Miller; Vahid Yaghmai; Paul Nikolaidis; Edward Wang; Talia Baker; Michael Abecassis; Al B Benson; Reed A Omary; Riad Salem
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

5.  FRZB up-regulated in hepatocellular carcinoma bone metastasis.

Authors:  Jia Huang; Wenhao Hu; Xiangjin Lin; Xuanwei Wang; Ketao Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

6.  Pulmonary resection for metastases from hepatocellular carcinoma.

Authors:  Fengshi Chen; Kiyoshi Sato; Takuji Fujinaga; Makoto Sonobe; Tsuyoshi Shoji; Hiroaki Sakai; Ryo Miyahara; Toru Bando; Kenichi Okubo; Toshiki Hirata; Hiroshi Date
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

Review 7.  Liver transplantation for hepatocellular carcinoma.

Authors:  Jerome Byam; John Renz; J Michael Millis
Journal:  Hepatobiliary Surg Nutr       Date:  2013-02       Impact factor: 7.293

Review 8.  Natural history of hepatitis-related hepatocellular carcinoma.

Authors:  David-Yiu-Kuen But; Ching-Lung Lai; Man-Fung Yuen
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

9.  Natural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.

Authors:  Daniele Santini; Francesco Pantano; Ferdinando Riccardi; Giovan Giuseppe Di Costanzo; Raffaele Addeo; Francesco Maria Guida; Mariella Spalato Ceruso; Sandro Barni; Paola Bertocchi; Sara Marinelli; Paolo Marchetti; Antonio Russo; Mario Scartozzi; Luca Faloppi; Matteo Santoni; Stefano Cascinu; Evaristo Maiello; Franco Silvestris; Marco Tucci; Toni Ibrahim; Gianluca Masi; Antonio Gnoni; Alessandro Comandone; Nicola Fazio; Alessandro Conti; Ilaria Imarisio; Salvatore Pisconti; Elisa Giommoni; Saverio Cinieri; Vincenzo Catalano; Vincenzo Ostilio Palmieri; Giovanni Infante; Michele Aieta; Antonio Trogu; Cosmo Damiano Gadaleta; Anna Elisabetta Brunetti; Vito Lorusso; Nicola Silvestris
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

10.  Surgical treatment of extrahepatic recurrence of hepatocellular carcinoma.

Authors:  Fumitoshi Hirokawa; Michihiro Hayashi; Yoshiharu Miyamoto; Mitsuhiro Asakuma; Tetsunosuke Shimizu; Koji Komeda; Yoshihiro Inoue; Kazuhisa Uchiyama
Journal:  Langenbecks Arch Surg       Date:  2014-07-17       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.